SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-20-016446
Filing Date
2020-11-13
Accepted
2020-11-13 17:16:11
Documents
57
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cpix-20200930.htm   iXBRL 10-Q 1093371
2 EX-10.1 a2020q3-exhibit101.htm EX-10.1 36609
3 EX-31.1 a2020q3-exhibit311.htm EX-31.1 12771
4 EX-31.2 a2020q3-exhibit312.htm EX-31.2 12780
5 EX-32.1 a2020q3-exhibit321.htm EX-32.1 7066
  Complete submission text file 0001628280-20-016446.txt   4751437

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cpix-20200930.xsd EX-101.SCH 31680
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cpix-20200930_cal.xml EX-101.CAL 80608
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cpix-20200930_def.xml EX-101.DEF 132437
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cpix-20200930_lab.xml EX-101.LAB 404239
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cpix-20200930_pre.xml EX-101.PRE 259528
11 EXTRACTED XBRL INSTANCE DOCUMENT cpix-20200930_htm.xml XML 691118
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 201312565
SIC: 2834 Pharmaceutical Preparations